China, Sept. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Exploring safety-optimized anticoagulation approaches for blood purification therapy in critically ill patients'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132483
Registration Time: 2026/09/15
Type: Observational study
Primary Sponsor: THE FIRST PEOPLE'S HOSPITAL OF WENLING
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=307758
Published by HT Digital Content Services with permission from Health Daily Digest....